Empowering API Development with UQUIFA Group’s One-Stop Shop Approach Using Specialized Units for Ea
Published on 06-13-202303:23 PM by
a_borsuk| Updated on 06-13-202303:24 PM
Meet a prospective partner, focused on offering solutions for your fine chemistry challenges. Hear how this active pharmaceutical ingredients (API) & regulated starting materials (RSM) focused enterprise brings together its chemistry skills & proprietary expertise to meet development & manufacturing needs.
We are able to handle API development projects from the very early discovery phase throughout pre-clinical and clinical development to the commercial phase. Learn how we developed API production technology for early clinical trials at our Hungarian sites, then transferred the technology for the GMP validation campaign to our Spanish site to accommodate Phase 3 clinical and future commercial needs for a US biotech partner.
Key Learning Objectives:
Concept of the One-stop shop
How to partner from early phase discovery through commercial production
Specialized technologies: metathesis, flow and particle size distribution
Who Should Attend:
Brought to you by:
Maria Lloris, Ph.D. R&D Manager, UQUIFA
Tamás Szabó Ph.D. R&D Director, SONEAS Chemicals Ltd
Melissa O'Meara Forensic Science Consultant, C&EN Media Group